India, April 19 -- Entod Pharmaceuticals marks a significant milestone with the approval of PresVu, a revolutionary Treatment for presbyopia, by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

PresVu emerges as the first-of-its-kind eye drop in India designed to alleviate the need for reading glasses among individuals grappling with presbyopia, a prevalent age-related vision impairment affecting millions.

Presbyopia, characterised by blurred near vision due to the decreased flexibility of the eye's natural lens, primarily impacts individuals aged 40 and above.

With PresVu, Entod Pharmaceuticals introduces a game-changing intervention, offering swift relief and temporary correction of visio...